BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 22134519)

  • 1. Complication rates in patients with negative axillary nodes 10 years after local breast radiotherapy after either sentinel lymph node dissection or axillary clearance.
    Wernicke AG; Shamis M; Sidhu KK; Turner BC; Goltser Y; Khan I; Christos PJ; Komarnicky-Kocher LT
    Am J Clin Oncol; 2013 Feb; 36(1):12-9. PubMed ID: 22134519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A 10-year follow-up of treatment outcomes in patients with early stage breast cancer and clinically negative axillary nodes treated with tangential breast irradiation following sentinel lymph node dissection or axillary clearance.
    Wernicke AG; Goodman RL; Turner BC; Komarnicky LT; Curran WJ; Christos PJ; Khan I; Vandris K; Parashar B; Nori D; Chao KS
    Breast Cancer Res Treat; 2011 Feb; 125(3):893-902. PubMed ID: 20853176
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Surgical complications associated with sentinel lymph node dissection (SLND) plus axillary lymph node dissection compared with SLND alone in the American College of Surgeons Oncology Group Trial Z0011.
    Lucci A; McCall LM; Beitsch PD; Whitworth PW; Reintgen DS; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Giuliano AE;
    J Clin Oncol; 2007 Aug; 25(24):3657-63. PubMed ID: 17485711
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial.
    Giuliano AE; Hunt KK; Ballman KV; Beitsch PD; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; McCall LM; Morrow M
    JAMA; 2011 Feb; 305(6):569-75. PubMed ID: 21304082
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Locoregional Recurrence After Sentinel Lymph Node Dissection With or Without Axillary Dissection in Patients With Sentinel Lymph Node Metastases: Long-term Follow-up From the American College of Surgeons Oncology Group (Alliance) ACOSOG Z0011 Randomized Trial.
    Giuliano AE; Ballman K; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Morrow M; Hunt KK
    Ann Surg; 2016 Sep; 264(3):413-20. PubMed ID: 27513155
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial.
    Giuliano AE; McCall L; Beitsch P; Whitworth PW; Blumencranz P; Leitch AM; Saha S; Hunt KK; Morrow M; Ballman K
    Ann Surg; 2010 Sep; 252(3):426-32; discussion 432-3. PubMed ID: 20739842
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The evolution of the sentinel node procedure in the treatment of breast cancer.
    Tvedskov TF
    Dan Med J; 2017 Oct; 64(10):. PubMed ID: 28975889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When is a lymph node dissection a lymph node dissection? The number of lymph nodes resected in sentinel and axillary lymph node dissections.
    Olaya W; Wong J; Wong J; Morgan J; Kazanjian K; Lum S
    Ann Surg Oncol; 2013 Feb; 20(2):627-32. PubMed ID: 22956069
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Axillary Dissection vs No Axillary Dissection on 10-Year Overall Survival Among Women With Invasive Breast Cancer and Sentinel Node Metastasis: The ACOSOG Z0011 (Alliance) Randomized Clinical Trial.
    Giuliano AE; Ballman KV; McCall L; Beitsch PD; Brennan MB; Kelemen PR; Ollila DW; Hansen NM; Whitworth PW; Blumencranz PW; Leitch AM; Saha S; Hunt KK; Morrow M
    JAMA; 2017 Sep; 318(10):918-926. PubMed ID: 28898379
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Axillary lymph node recurrence following wire-directed sentinel lymph node dissection for breast cancer patients with biopsy-proven axillary metastases prior to neoadjuvant chemotherapy at a safety net medical center.
    Sargent RE; Siegel E; Ito F; Kramme K; Kraft E; Hendrix V; Carr AA; Nelson ME; Bian SX; Jayachandran P; Sener SF
    J Surg Oncol; 2023 Jul; 128(1):9-15. PubMed ID: 36933187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer.
    Giuliano AE; Haigh PI; Brennan MB; Hansen NM; Kelley MC; Ye W; Glass EC; Turner RR
    J Clin Oncol; 2000 Jul; 18(13):2553-9. PubMed ID: 10893286
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Arm morbidity of axillary dissection with sentinel node biopsy versus delayed axillary dissection.
    Ballal H; Hunt C; Bharat C; Murray K; Kamyab R; Saunders C
    ANZ J Surg; 2018 Sep; 88(9):917-921. PubMed ID: 29392828
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Improved axillary staging of breast cancer with sentinel lymphadenectomy.
    Giuliano AE; Dale PS; Turner RR; Morton DL; Evans SW; Krasne DL
    Ann Surg; 1995 Sep; 222(3):394-9; discussion 399-401. PubMed ID: 7677468
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of upper extremity lymphedema after sentinel lymph node biopsy and axillary lymph node dissection: patient-reported outcomes in 3044 patients.
    Poulsen L; Kaur M; Jacobsen AL; Bjarnesen MP; Bjarnesen AP; Klassen AF; Pusic AL; de Vries CEE; Sørensen JA
    Breast Cancer Res Treat; 2022 Jan; 191(1):87-96. PubMed ID: 34643834
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Morbidity results from the NSABP B-32 trial comparing sentinel lymph node dissection versus axillary dissection.
    Ashikaga T; Krag DN; Land SR; Julian TB; Anderson SJ; Brown AM; Skelly JM; Harlow SP; Weaver DL; Mamounas EP; Costantino JP; Wolmark N;
    J Surg Oncol; 2010 Aug; 102(2):111-8. PubMed ID: 20648579
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Obesity is a risk factor for developing postoperative lymphedema in breast cancer patients.
    Helyer LK; Varnic M; Le LW; Leong W; McCready D
    Breast J; 2010; 16(1):48-54. PubMed ID: 19889169
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of side effects between sentinel lymph node and axillary lymph node dissection for breast cancer.
    Swenson KK; Nissen MJ; Ceronsky C; Swenson L; Lee MW; Tuttle TM
    Ann Surg Oncol; 2002 Oct; 9(8):745-53. PubMed ID: 12374657
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sentinel lymph node dissection provides axillary control equal to complete axillary node dissection in breast cancer patients with lobular histology and a negative sentinel node.
    Khakpour N; Hunt KK; Kuerer HM; Yi M; Meric-Bernstam F; Ross MI; Lucci A
    Am J Surg; 2005 Oct; 190(4):598-601. PubMed ID: 16164930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphedema following breast cancer treatment, including sentinel lymph node biopsy.
    Armer J; Fu MR; Wainstock JM; Zagar E; Jacobs LK
    Lymphology; 2004 Jun; 37(2):73-91. PubMed ID: 15328760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Axillary disease recurrence after sentinel lymph node dissection for breast carcinoma.
    Swenson KK; Mahipal A; Nissen MJ; Tuttle TM; Heaton K; Lally RM; Spomer A; Lee MW
    Cancer; 2005 Nov; 104(9):1834-9. PubMed ID: 16161037
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.